Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) reported Q3 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $12.5 million versus the consensus estimate of $13.05 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals, Inc. (CPIX) click here.

Earnings